Gingival Recession – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034
Gingival Recession Market Outlook
Thelansis’s “Gingival Recession Market
Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024
To 2034" covers disease overview, epidemiology, drug utilization,
prescription share analysis, competitive landscape, clinical practice,
regulatory landscape, patient share, market uptake, market forecast, and key
market insights under the potential Gingival Recession treatment modalities
options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan,
and China).
Gingival Recession Overview
Gingival
recession, also known as soft tissue recession, is characterized by the
displacement of the gingival margin below the cementoenamel junction (CEJ) of a
tooth or the platform of a dental implant. This condition involves the loss of
various periodontal tissues, including gingiva, periodontal ligament, root
cementum, and bone at dental sites, and the loss of mucosa and bone around
dental implants. The underlying causes of gingival recession encompass a range
of factors, such as inflammatory periodontal diseases, trauma resulting from
aggressive oral hygiene practices, recurrent inflammation due to bone
dehiscence or fenestration beneath the gingiva, repeated inflammation linked to
poorly fitting dental restorations, orthodontic-induced tooth movement through
the labial bone plate, viral-induced ulceration of the gingival margin,
cytotoxic drug-induced ulceration, benign familial neutropenia, traumatic
injuries to the gingival margin, and compromised blood supply to the gingiva.
Signs and symptoms that may indicate the presence of gingival recession include
tooth mobility heightened tooth sensitivity characterized by short and intense
pain, apparent elongation of teeth due to receding gums, visible exposure of
tooth roots, formation of notches at the gum line of affected teeth,
alterations in tooth color attributed to the differing shades between enamel
and cementum, perception of increased spacing between teeth due to reduced gum
coverage, and occurrence of cavities beneath the gum line. Additionally, gingival
recession elevates the susceptibility to root surface caries development.
Gingival recession is also commonly observed in pediatric populations. Several
factors contribute to the predisposition of patients to developing gingival
recession, including the presence of a narrow band of attached or keratinized
gingiva, alveolar bony dehiscence, trauma from toothbrushing, prominent teeth,
constraining frenum attachment, soft tissue interference from opposing
occlusion, orthodontic tooth movement, utilization of impression techniques
involving subgingival tissue retraction, oral habits, periodontitis, pseudo
recession (extrusion of teeth), and intraoral piercings like tongue piercings.
Numerous classification systems have been introduced to categorize gingival
recession. Miller’s classification system is the most widely adopted.
Nevertheless, many cases cannot be effectively categorized based on the
criteria of standard classification systems. An alternative classification
system proposed by Kumar & Masamatti offers a comprehensive representation
of recession defects and accommodates cases that cannot be classified using
existing systems. Predominantly employed methods for treating gingival
recession defects encompass pedicle flap surgical techniques, such as coronally
advanced or rotational flaps.
Geography coverage:
G8 (United States, EU5 [France,
Germany, Italy, Spain, U.K.], Japan, and China)
Insights driven by robust
research, including:
- In-depth interviews with leading KOLs and payers
- Physician surveys
- RWE analysis for claims and EHR datasets
- Secondary research (e.g., peer-reviewed journal
articles, third-party research databases)
Deliverables format and
updates*:
- Detailed Report (PDF)
- Market Forecast Model (MS Excel-based automated
dashboard)
- Epidemiology (MS Excel; interactive tool)
- Executive Insights (PowerPoint presentation)
- Others: regular updates, customizations, consultant
support
*As per Thelansis’s policy, we
ensure that we include all the recent updates before releasing the report
content and market model.
Salient features of Market
Forecast model:
- 10-year market forecast (2024–2034)
- Bottom-up patient-based market forecasts validated
through the top-down sales methodology
- Covers clinically and commercially-relevant patient
populations/ line of therapies
- Annualized drug-level sales and patient share
projections
- Utilizes our proprietary Epilansis and Analog tool
(e.g., drug uptake and erosion) datasets and conjoint analysis approach
- Detailed methodology/sources & assumptions
- Graphical and tabular outputs
- Users can customize the model based on requirements
Key business questions answered:
- How can drug development and lifecycle management
strategies be optimized across G8 markets (US, EU5, Japan, and China)?
- How large is the patient population in terms of
incidence, prevalence, segments, and those receiving drug treatments?
- What is the 10-year market outlook for sales and
patient share?
- Which events will have the greatest impact on the
market’s trajectory?
- What insights do interviewed experts provide on
current and emerging treatments?
- Which pipeline products show the most promise, and
what is their potential for launch and future positioning?
- What are the key unmet needs and KOL expectations for
target profiles?
- What key regulatory and payer requirements must be
met to secure drug approval and favorable market access?
- and more…
Comments
Post a Comment